Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria.

Ariceta G, Barrios K, Brown BD, Hoppe B, Rosskamp R, Langman CB

Open source

DOI
10.1016/j.ekir.2021.01.029
Published
2021 Apr
Container
Kidney international reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ekir.2021.01.029,
  title = {Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria.},
  author = {Ariceta G and Barrios K and Brown BD and Hoppe B and Rosskamp R and Langman CB},
  year = {2021},
  journal = {Kidney international reports},
  doi = {10.1016/j.ekir.2021.01.029},
  url = {https://doi.org/10.1016/j.ekir.2021.01.029}
}

RIS

TY  - JOUR
TI  - Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria.
AU  - Ariceta G
AU  - Barrios K
AU  - Brown BD
AU  - Hoppe B
AU  - Rosskamp R
AU  - Langman CB
PY  - 2021
JO  - Kidney international reports
DO  - 10.1016/j.ekir.2021.01.029
UR  - https://doi.org/10.1016/j.ekir.2021.01.029
ER  - 

APA

G, A., K, B., BD, B., B, H., R, R., & CB, L. (2021). Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria.. Kidney international reports. https://doi.org/10.1016/j.ekir.2021.01.029

Source records